The U.S. Food and Drug Administration (FDA) initially approved the Rotavirus vaccine on  April 3, 2008.

Rotavirus vaccines prevent rotavirus infection in pediatric healthcare in infants and young children. These vaccines effectively reduce the severity and duration of diarrhea and vomiting, which can lead to dehydration and hospitalization. They contribute to public health by lowering the overall incidence of rotavirus infections, improving child health, and supporting global health initiatives. Additionally, they establish herd immunity, protecting vulnerable populations.

Rotavirus vaccine is administered orally in liquid drops or using an oral syringe. This mode of administration is well-suited for infants and young children and involves giving the vaccine by mouth. The vaccines are typically given at specific intervals, following a recommended dosing schedule, to ensure optimal protection.

Rotavirus vaccines typically have mild and temporary side effects. Common side effects can include irritability, mild diarrhea or vomiting, low-grade fever, and soreness at the injection site (for Rotarix, oral administration). Serious side effects are rare but can include a very low risk of intussusception, a rare intestinal condition, particularly after the first dose. Severe allergic reactions (anaphylaxis) are also extremely rare. 

While the risk is extremely low, there is a potential association between rotavirus vaccines and intussusception, a rare intestinal condition where one part of the intestine telescopes into another. Severe allergic reactions (anaphylaxis) to vaccine components are rare but possible. Certain medical conditions, such as severe immunodeficiency disorders or a history of intussusception, may require special precautions.

Parents and caregivers should be aware of the signs and symptoms of intussusception, such as severe abdominal pain, vomiting, and bloody stools, and seek immediate medical attention if these symptoms occur after taking rotavirus. Individuals with known allergies to specific vaccine ingredients should inform their healthcare provider before vaccination.  Some medical conditions, such as severe immunodeficiency disorders, a history of intussusception, or known allergies to vaccine components, may require special precautions or considerations before vaccination.

After taking the Rotavirus vaccine, evaluate individuals with moderate to severe acute illnesses, a history of gastrointestinal disorders, previous intussusception, severe immunodeficiency disorders, known allergies to vaccine components, households with immunocompromised members, and those with special medical conditions. Additionally, premature infants and individuals who have experienced significant adverse reactions to previous vaccine doses may warrant specific precautions. It's crucial to adhere to recommended age and dosing schedules, maintain vaccine brand consistency throughout the series, and follow proper storage and handling guidelines. Open communication with healthcare professionals is essential to address any concerns or questions about vaccination precautions effectively and to ensure this vaccine's safe and effective use.

1. GlaxoSmithKline Limited; European medicines compendium (emc); [Revised on 31th Oct 2022]; [ Accessed on  6th September 2023]https://www.medicines.org.uk/emc/product/2739/smpc#gref 
2. GlaxoSmithKline Limited); U.S Food and drug administration; [Revised on 11th July 2022]; [ Accessed on 6th September 2023]; https://www.fda.gov/vaccines-blood-biologics/vaccines/rotarix#:~:text=Indication%3A,to%2024%20weeks%20of%20age. 
3. Vesikari T. Rotavirus vaccination: a concise review; Clinical microbiology and infection; Published on October 2012 [Accessed on 6th September 2023]https://pubmed.ncbi.nlm.nih.gov/15246619/#:~:text=No%20side%20effects%20were%20seen,doses%2C%20depending%20on%20vaccine%20titer. 

The drug information on this page is not a substitute for medical advice; it is meant for educational purposes only. For further details, consult your doctor about your medical condition to know if you can receive this treatment.